You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 10, October 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (56)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Choroidal Neovascularization
 •Macular Degeneration
 •Radiologic Imaging
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Polypoidal Choroidal Vasculopathy

Incidence, Demographic Features, and Clinical Characteristics

Kenichiro Sho, MD; Kanji Takahashi, MD; Haruhiko Yamada, MD; Mitsumasa Wada, MD; Yoshimi Nagai, MD; Tsuyoshi Otsuji, MD; Maki Nishikawa, MD; Yumiko Mitsuma, MD; Yukari Yamazaki, MD; Miyo Matsumura, MD; Masanobu Uyama, MD

Arch Ophthalmol. 2003;121:1392-1396.

Objective  To clarify the incidence, demographic features, and clinical characteristics of polypoidal choroidal vasculopathy (PCV) in Japanese patients.

Methods  Consecutive patients with presumed neovascular age-related macular degeneration (AMD) who met the eligibility criteria were examined between January 1, 1999, and October 31, 2001. All patients underwent complete ophthalmologic examination and fluorescein and indocyanine green angiography.

Results  Among 471 eyes of 418 patients who met the criteria, 110 eyes (23%) of 100 patients were diagnosed as having PCV and 361 eyes (77%) of 318 patients as having neovascular AMD. Mean age of patients with PCV was 68.4 years, with a male preponderance (63% of patients); involvement was mostly unilateral (90% of patients), and polypoidal vascular lesions were located mainly in the macula (85% of eyes). Retinal manifestations of PCV were characterized by serous macular detachment (52% of eyes), submacular hemorrhage (30% of eyes), and retinal pigment epithelium degeneration (10% of eyes). There were few subretinal fibrovascular proliferations (7% of eyes). Mean visual acuity was 0.31 in eyes with PCV and 0.18 in eyes with AMD. The incidence of severe visual loss (0.2 or worse) was 35% in PCV and 53% in AMD.

Conclusions  The incidence of PCV in Japanese patients is high, and the incidence and demographic features vary in different ethnic groups. The clinical manifestations of PCV and AMD resemble each other; however, PCV is characterized by low incidence of subretinal fibrovascular proliferation, slow progression of vascular abnormality, and minimal association with conventional choroidal neovascularization. These factors seem to lead to a more favorable visual outcome in PCV compared with neovascular AMD.


From the Department of Ophthalmology, Kansai Medical University, Fumizono-cho, Moriguchi, Osaka, Japan. The authors have no relevant financial interest in this article.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Polypoidal choroidal vasculopathy and late geographic hyperfluorescence on indocyanine green angiography
Kang et al.
Br J Ophthalmol 2009;93:759-764.
ABSTRACT | FULL TEXT  

Photodynamic therapy with verteporfin for age-related macular degeneration or polypoidal choroidal vasculopathy: comparison of the presence of serous retinal pigment epithelial detachment
Saito et al.
Br J Ophthalmol 2008;92:1642-1647.
ABSTRACT | FULL TEXT  

Clinicopathologic Findings in Polypoidal Choroidal Vasculopathy
Nakashizuka et al.
IOVS 2008;49:4729-4737.
ABSTRACT | FULL TEXT  

Prevalence and Associated Risk Factors of Age-Related Macular Degeneration in an Elderly Chinese Population in Taiwan: The Shihpai Eye Study
Chen et al.
IOVS 2008;49:3126-3133.
ABSTRACT | FULL TEXT  

Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy
Wakabayashi et al.
Br J Ophthalmol 2008;92:936-940.
ABSTRACT | FULL TEXT  

Association Analysis of CFH, C2, BF, and HTRA1 Gene Polymorphisms in Chinese Patients with Polypoidal Choroidal Vasculopathy
Lee et al.
IOVS 2008;49:2613-2619.
ABSTRACT | FULL TEXT  

Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy
Gomi et al.
Br J Ophthalmol 2008;92:70-73.
ABSTRACT | FULL TEXT  

Coding and Noncoding Variants in the CFH Gene and Cigarette Smoking Influence the Risk of Age-Related Macular Degeneration in a Japanese Population
Mori et al.
IOVS 2007;48:5315-5319.
ABSTRACT | FULL TEXT  

Polypoidal choroidal vasculopathy with an appearance similar to classic choroidal neovascularisation on fluorescein angiography
Iida
Br J Ophthalmol 2007;91:1103-1104.
FULL TEXT  

Polypoidal choroidal vasculopathy
Mori and Eguchi
Br J Ophthalmol 2007;91:1104-1105.
FULL TEXT  

Polypoidal choroidal vasculopathy appearing as classic choroidal neovascularisation on fluorescein angiography
Tamura et al.
Br J Ophthalmol 2007;91:1152-1159.
ABSTRACT | FULL TEXT  

Pars plana vitrectomy with peripheral retinotomy after injection of preoperative intravitreal tissue plasminogen activator: a modified procedure to drain massive subretinal haemorrhage
Oshima et al.
Br J Ophthalmol 2007;91:193-198.
ABSTRACT | FULL TEXT  

A Clinician's View of the Molecular Genetics of Age-Related Maculopathy
Gorin
Arch Ophthalmol 2007;125:21-29.
ABSTRACT | FULL TEXT  

The origins of polypoidal choroidal vasculopathy
Yuzawa et al.
Br J Ophthalmol 2005;89:602-607.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.